|
|
Article: ALZA Acquires Flexeril(R) Product and Trademark in United States and Canada.
- Article from:
- PR Newswire
- Article date:
- February 5, 2001
CopyrightCOPYRIGHT 2001 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
MOUNTAIN VIEW, Calif., Feb. 5 /PRNewswire/ --
ALZA Corporation (NYSE: AZA) today announced that it has acquired certain marketing rights to the Flexeril(R) (cyclobenzaprine) product and trademark from Merck and Co., Inc. (NYSE: MRK). ALZA is currently developing a novel once-a-day OROS(R) formulation of cyclobenzaprine.
(Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/19991124/ALZALOGO )
Under the terms of the agreement, ALZA will obtain exclusive sales and marketing rights for Flexeril(R) and the exclusive license to the Flexeril(R) trademark for pharmaceutical sales, in the United States and Canada, in each case excluding ...